[Concept for routine practice data collection acc. to the Law for More Safety in the Supply of Medicines (GSAV) – exagamglogene autotemcel (beta-thalassaemia)]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005560
German
Original Title: Exagamglogen Autotemcel (Beta-Thalassämie)
Details
Project Status: Completed
URL for project: https://www.iqwig.de/projekte/a23-67.html
Year Published: 2023
URL for published report: https://www.iqwig.de/download/a23-67_exagamglogen-autotemcel_abd-konzept_v1-0.pdf
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
DOI: https://doi.org/10.60584/A23-67
MeSH Terms
  • beta-Thalassemia
  • Adolescent
  • Adult
  • Genetic Therapy
  • Registries
  • Product Surveillance, Postmarketing
  • Biological Products
Keywords
  • Exagamglogene Autotemcel
  • Beta-Thalassemia
  • Adolescent
  • Adult
  • Registries
  • Benefit Assessment
  • Concept
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.